Hydrocodone in long system

Hydrocodone in long system

Shareholding of our Directors and Key Managerial Personnel Except as set forth below, none of our Directors or Key Managerial Personnel hold any Equity Shares as on the date of this DRHP: S. Name of shareholder Number of Equity Pre Issue buy o tramadol % Post Issue % No. Shares held 1. Hasmukh Chudgar 3,597,487 3.14 [•1 S. Name of shareholder Number of Equity Pre Issue % Post Issue %* No. Shares held 2. Mr. Nimish Hasmukhbhai Chudgar 6,438,707 5.63 [•1 4. Dr.

Urmish Hasmukh Chudgar 113,533 0.10 [•1 Total 1,6358,874 14.30 [•] 6.

Top ten shareholders As on the date of hydrocodone in long system this DRHP, our Company has 14 holders of Equity Shares.

(a) Our top ten Equity Shareholders and the number of Equity Shares held by them, as on the date of this DRHP: S. of Equity Shares Pre Issue % 1. Equatorial Private Limited 47,432,000 41.45 2. Mozart Limited 11,621,100 10.16 3. Ms.

Bindi Chudgar 6,906,389 6.04 5. Caravaggio 6,898,447 6.03 6. Mr. Shail Chudgar 4,796,967 4.19 10. Intas Enterprise Private Limited 4,106,667 3.59 (b) Our top ten Equity Shareholders and the number of Equity Shares held by them ten days prior to filing of this DRHP: S. of Equity Shares Pre Issue % 1. Equatorial Private Limited 46,200,000 41.86 2. Mozart Limited 11,621,100 10.53 3. Caravaggio 6,898,447 6.25 4. Ms. Shail Chudgar 4,661,980 4.22 10. Intas Enterprise Private Limited 4,000,000 3.62 (c) Our top ten Equity Shareholders two years prior to filing of this DRHP: S. of Equity Shares Held Pre Issue % 1. Equatorial Private Limited 46,200,000 44.65 2. Mozart Limited 11,621,100 11.23 3. Ms. Shail Chudgar 4,661,980 4.51 9. Intas Enterprise Private Limited 4,000,000 3.87 10. Mr. Employee Stock Option Plan Pursuant to a resolution of our shareholders dated February 10, 2011, our Company has implemented the ESOS Scheme, whose objective is to reward our directors and permanent employees, including those of our Subsidiaries. As per the certificate dated June 12, 2013 provided by Apaji Amin & Company, Chartered Accountants, the ESOS Scheme is in compliance with applicable regulations, including relevant Guidance Notes or Accounting Standards issued by the Institute of Chartered Accountants of India in this regard and the ESOP Guidelines. Under the provisions of the ESOS Scheme, we intend to grant up to 2,586,000 employee stock options, constituting 2.5% of paid-up Equity Shares as on January 15, 2011, to the eligible employees and Directors of our Company and our Subsidiaries. These employee stock options, upon vesting and exercise, will enable the employees to an equal number of Equity Shares. The exercise price of the options under the ESOS Scheme shall be 50% of Issue Price. In the event of any bonus/split/rights issue of equity lisinopril cough hydrocodone homatrophine shares, the entitlement of Equity Shares will be suitably revised.

As on the date of the filing of this DRHP, we have not granted any employee stock option pursuant to the ESOS Scheme. Our Company, our Directors and the BRLMs have not entered into any buy-back and/or standby and/or any other similar arrangements for the purchase of Equity Shares being offered through this Issue.

Except as disclosed under the section titled "Capital Structure - History of equity share capital of our Company" on page 63, our Company has not issued any Equity Shares at a price less than the Issue Price in the last one year preceding the date of filing apap oxycodone percocet of this DRHP. 10.The BRLMs do not hold any Equity Shares as on the date of filing of this DRHP. The hydrocodone in long system BRLMs and their respective affiliates may engage hydrocodone in long system in the transactions with and perform services for our Company and our Subsidiaries hydrocodone in long system in the ordinary course of business or may in the future engage in commercial banking and investment buy hydrocodone by mail banking transactions with our Company and our Subsidiaries, for which they may in future receive customary compensation. 11.The BRLMs, the members of the Syndicate, our Company, the Directors, the Subsidiaries, the Promoters, the Promoter Group and the Group Companies, shall not offer any incentive, whether direct or indirect, in any manner, whether in cash or kind or services or otherwise to any Bidder for making a Bid.



Owner phentermine viagra xanax
Hydrocodone in malaysia
Prescriptions phentermine no prescription needed